Cargando…

Risk and protective factors for opioid overdose during the COVID-19 pandemic

INTRODUCTION: People who use drugs (PWUD) are now at the intersection of two public health emergencies – the Covid-19 pandemic and the overdose crisis. They may be at heightened risk of overdose due to increased isolation, worsened mental health, and changes to the illicit drug supply. The province...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, J., Westenberg, J., Mathew, N., Azar, P., Krausz, R.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480382/
http://dx.doi.org/10.1192/j.eurpsy.2021.2179
_version_ 1784791042152726528
author Wong, J.
Westenberg, J.
Mathew, N.
Azar, P.
Krausz, R.M.
author_facet Wong, J.
Westenberg, J.
Mathew, N.
Azar, P.
Krausz, R.M.
author_sort Wong, J.
collection PubMed
description INTRODUCTION: People who use drugs (PWUD) are now at the intersection of two public health emergencies – the Covid-19 pandemic and the overdose crisis. They may be at heightened risk of overdose due to increased isolation, worsened mental health, and changes to the illicit drug supply. The province of British Columbia (BC) in Canada is anticipated to experience a record-breaking year of overdose deaths as over 1,500 people (32.9 deaths per 100,000) have died from overdose in 2020. In response, BC released new clinical guidelines in March to allow the prescribing of pharmaceutical alternatives aiming to reduce PWUD’s risk of overdose and contracting Covid-19. OBJECTIVES: We examined the risk and protective factors for overdose during these dual crises. We explored how the Covid-19 pandemic has impacted the mental health and substance use of PWUD and their access to treatment and harm reduction services. METHODS: We are conducting a survey among patients with opioid use disorder at a major hospital in Vancouver, BC. It includes the following domains: sociodemographic characteristics; mental and physical health; substance use patterns; opioid overdose history; access to treatment, harm reduction services; impacts of Covid-19. RESULTS: We anticipate collecting data from 200 participants. Descriptive statistics and regression analysis will be conducted to describe the sample and determine the risk, protective factors for overdose. CONCLUSIONS: We will gain a better understanding of overdose risk in PWUD who are now navigating the complex challenges created by the dual crises. This will in turn inform the establishment of evidence-based strategies to reduce their overdose risk. DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9480382
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-94803822022-09-29 Risk and protective factors for opioid overdose during the COVID-19 pandemic Wong, J. Westenberg, J. Mathew, N. Azar, P. Krausz, R.M. Eur Psychiatry Abstract INTRODUCTION: People who use drugs (PWUD) are now at the intersection of two public health emergencies – the Covid-19 pandemic and the overdose crisis. They may be at heightened risk of overdose due to increased isolation, worsened mental health, and changes to the illicit drug supply. The province of British Columbia (BC) in Canada is anticipated to experience a record-breaking year of overdose deaths as over 1,500 people (32.9 deaths per 100,000) have died from overdose in 2020. In response, BC released new clinical guidelines in March to allow the prescribing of pharmaceutical alternatives aiming to reduce PWUD’s risk of overdose and contracting Covid-19. OBJECTIVES: We examined the risk and protective factors for overdose during these dual crises. We explored how the Covid-19 pandemic has impacted the mental health and substance use of PWUD and their access to treatment and harm reduction services. METHODS: We are conducting a survey among patients with opioid use disorder at a major hospital in Vancouver, BC. It includes the following domains: sociodemographic characteristics; mental and physical health; substance use patterns; opioid overdose history; access to treatment, harm reduction services; impacts of Covid-19. RESULTS: We anticipate collecting data from 200 participants. Descriptive statistics and regression analysis will be conducted to describe the sample and determine the risk, protective factors for overdose. CONCLUSIONS: We will gain a better understanding of overdose risk in PWUD who are now navigating the complex challenges created by the dual crises. This will in turn inform the establishment of evidence-based strategies to reduce their overdose risk. DISCLOSURE: No significant relationships. Cambridge University Press 2021-08-13 /pmc/articles/PMC9480382/ http://dx.doi.org/10.1192/j.eurpsy.2021.2179 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Wong, J.
Westenberg, J.
Mathew, N.
Azar, P.
Krausz, R.M.
Risk and protective factors for opioid overdose during the COVID-19 pandemic
title Risk and protective factors for opioid overdose during the COVID-19 pandemic
title_full Risk and protective factors for opioid overdose during the COVID-19 pandemic
title_fullStr Risk and protective factors for opioid overdose during the COVID-19 pandemic
title_full_unstemmed Risk and protective factors for opioid overdose during the COVID-19 pandemic
title_short Risk and protective factors for opioid overdose during the COVID-19 pandemic
title_sort risk and protective factors for opioid overdose during the covid-19 pandemic
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480382/
http://dx.doi.org/10.1192/j.eurpsy.2021.2179
work_keys_str_mv AT wongj riskandprotectivefactorsforopioidoverdoseduringthecovid19pandemic
AT westenbergj riskandprotectivefactorsforopioidoverdoseduringthecovid19pandemic
AT mathewn riskandprotectivefactorsforopioidoverdoseduringthecovid19pandemic
AT azarp riskandprotectivefactorsforopioidoverdoseduringthecovid19pandemic
AT krauszrm riskandprotectivefactorsforopioidoverdoseduringthecovid19pandemic